The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Mutational signatures associated with tobacco smoking in human cancer
Open accessPublished version of a preprint
Abstract
Tobacco smoking increases the risk of at least 17 classes of human cancer. We analyzed somatic mutations and DNA methylation in 5243 cancers of types for which tobacco smoking confers an elevated risk. Smoking is associated with increased mutation burdens of multiple distinct mutational signatures, which contribute to different extents in different cancers. One of these signatures, mainly found in cancers derived from tissues directly exposed to tobacco smoke, is attributable to misreplication of DNA damage caused by tobacco carcinogens. Others likely reflect indirect activation of DNA editing by APOBEC cytidine deaminases and of an endogenous clocklike mutational process. Smoking is associated with limited differences in methylation. The results are consistent with the proposition that smoking increases cancer risk by increasing the somatic mutation load, although direct evidence for this mechanism is lacking in some smoking-related cancer types.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“TMB measured by comprehensive genomic profiling is comparable to measurements by whole exome sequencing and is typically higher in smoking associated lung cancer due to tobacco carcinogenesis”
From Diverse EGFR Exon 20 Insertions and Co-Occurring Molecular Alterations Identified by Comprehensive Genomic Profiling of NSCLC (2018) · cites this paper as [29]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lim, S. S., Vos, T., Flaxman, A. D., Danaei, G., Shibuya, K., Adair-Rohani, H., AlMazroa, M. A., Amann, M., Anderson, H. R., Andrews, K. G., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61766-8 · Cited by 11,805
Signatures of mutational processes in human cancer
Initiative, A. P. C. G., Alexandrov, L. B., ICGC Breast Cancer Consortium, ICGC MMML-Seq Consortium, PedBrain, I., Nik-Zainal, S., Wedge, D. C., Aparicio, S. A. J. R., Behjati, S., Biankin, A. V., et al. (2013) · Nature · doi:10.1038/nature12477 · Cited by 9,660
Self-citationAn integrated map of genetic variation from 1,092 human genomes
The 1000 Genomes Project Consortium (2012) · Nature · doi:10.1038/nature11632 · Cited by 7,711
dbSNP: the NCBI database of genetic variation
Sherry, S. T. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.1.308 · Cited by 7,502
Robust regression using iteratively reweighted least-squares.
Holland, P. W., & Welsch, R. E. (1977) · Communications in Statistics - Theory and Methods · doi:10.1080/03610927708827533 · Cited by 2,115
Mutational Processes Molding the Genomes of 21 Breast Cancers
Nik-Zainal, S., Alexandrov, L. B., Wedge, D. C., Van Loo, P., Greenman, C. D., Raine, K., Jones, D., Hinton, J., Marshall, J., Stebbings, L. A., et al. (2012) · Cell · doi:10.1016/j.cell.2012.04.024 · Cited by 1,909
Self-citationHuber, P. J., & Ronchetti, E. M. (2009) · Wiley series in probability and statistics · doi:10.1002/9780470434697 · Cited by 1,823
Schulze, K., Imbeaud, S., Letouzé, E., Alexandrov, L. B., Calderaro, J., Rebouissou, S., Couchy, G., Meiller, C., Shinde, J., Soysouvanh, F., et al. (2015) · Nature Genetics · doi:10.1038/ng.3252 · Cited by 1,803
Self-citationMapping the Hallmarks of Lung Adenocarcinoma with Massively Parallel Sequencing
Imielinski, M., Berger, A. H., Hammerman, P. S., Hernandez, B., Pugh, T. J., Hodis, E., Cho, J., Suh, J., Capelletti, M., Sivachenko, A., et al. (2012) · Cell · doi:10.1016/j.cell.2012.08.029 · Cited by 1,789
Preferential Formation of Benzo[ a ]pyrene Adducts at Lung Cancer Mutational Hotspots in P53
Denissenko, M. F., Pao, A., Tang, M.-S., & Pfeifer, G. P. (1996) · Science · doi:10.1126/science.274.5286.430 · Cited by 1,650
Flagged first, then by citations
Research works printed but not linked: 2
- D. H. Phillips in The Cancer Handbook M. R. Allison Ed. (Macmillan 2002) pp. 293–306.
- V. Barnett T. Lewis Outliers in Statistical Data (Wiley Series in Probability and Mathematical Statistics: Applied Probability and Statistics Wiley ed. 3 1994).
Cited by
Sorted by citations
Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden
Chalmers, Z. R., Connelly, C. F., Fabrizio, D., Gay, L., Ali, S. M., Ennis, R., Schrock, A., Campbell, B., Shlien, A., Chmielecki, J., et al. (2017) · Genome Medicine · doi:10.1186/s13073-017-0424-2 · Cited by 3,519
Pan-cancer analysis of whole genomes
The ICGC/TCGA Pan-Cancer Analysis of Whole Genomes Consortium, Aaltonen, L. A., Abascal, F., Abeshouse, A., Aburatani, H., Adams, D. J., Agrawal, N., Ahn, K. S., Ahn, S.-M., Aikata, H., et al. (2020) · Nature · doi:10.1038/s41586-020-1969-6 · Cited by 3,064
Self-citationKastenhuber, E. R., & Lowe, S. W. (2017) · Cell · doi:10.1016/j.cell.2017.08.028 · Cited by 1,906
A compendium of mutational cancer driver genes
Martínez-Jiménez, F., Muiños, F., Sentís, I., Deu-Pons, J., Reyes-Salazar, I., Arnedo-Pac, C., Mularoni, L., Pich, O., Bonet, J., Kranas, H., et al. (2020) · Nature reviews. Cancer · doi:10.1038/s41568-020-0290-x · Cited by 1,340
The Challenges of Tumor Mutational Burden as an Immunotherapy Biomarker
Jardim, D. L., Goodman, A., de Melo Gagliato, D., & Kurzrock, R. (2021) · Cancer Cell · doi:10.1016/j.ccell.2020.10.001 · Cited by 1,192
Small-cell lung cancer: what we know, what we need to know and the path forward
Gazdar, A. F., Bunn, P. A., & Minna, J. D. (2017) · Nature reviews. Cancer · doi:10.1038/nrc.2017.87 · Cited by 900
Gettinger, S., Choi, J., Hastings, K., Truini, A., Datar, I., Sowell, R., Wurtz, A., Dong, W., Cai, G., Melnick, M. A., et al. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-17-0593 · Cited by 787
“Our analysis revealed that in the majority of the tumor specimens the dominant mutation signatures were those associated with smoking, APOBEC mutations and to a lesser extent alkylating agents (26,27) (Supplementary Fig.”
BackgroundRelationships among smoking, oxidative stress, inflammation, macromolecular damage, and cancer
Caliri, A. W., Tommasi, S., & Nia, A. B. (2021) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2021.108365 · Cited by 750
“exposed in vitro/in vivo to complex mixture of chemicals, such as tobacco smoke [12,14,31,32,171,175].”
BackgroundMutationalPatterns: comprehensive genome-wide analysis of mutational processes
Blokzijl, F., Janssen, R., van Boxtel, R., & Cuppen, E. (2018) · Genome Medicine · doi:10.1186/s13073-018-0539-0 · Cited by 660
“Some mutational signatures could be linked to specific biological processes through association with exposure to carcinogens, such as tobacco smoke [6, 7], or the deficiency of DNA repair processes, such as nucleotide excision repair (NER) [8].”
BackgroundDNA Damage and Repair Biomarkers of Immunotherapy Response
Mouw, K. W., Goldberg, M. S., Konstantinopoulos, P. A., & D’Andrea, A. D. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-17-0226 · Cited by 664
“For example, tumors with a mutational landscape dominated by C>A transversions, a pattern linked to tobacco exposure (72), were more likely to benefit from ICB, and this genomic smoking signature was more predictive of ICB response than patientreported smoking history (54).”
Overview of oral cavity squamous cell carcinoma: Risk factors, mechanisms, and diagnostics
Chamoli, A., Gosavi, A., Shirwadkar, U. P., Wangdale, K. V., Behera, S. K., Kurrey, N. K., Kalia, K., & Mandoli, A. (2021) · Oral Oncology · doi:10.1016/j.oraloncology.2021.105451 · Cited by 616
Jin, Y., Dong, H., Xia, L., Yang, Y., Zhu, Y., Shen, Y., Zheng, H., Yao, C., Wang, Y., & Lu, S. (2019) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2019.04.007 · Cited by 573
Advances in molecular classification and precision oncology in hepatocellular carcinoma
Rebouissou, S., & Nault, J. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2019.08.017 · Cited by 603
Tobacco smoking and somatic mutations in human bronchial epithelium
Yoshida, K., Gowers, K. H. C., Lee-Six, H., Chandrasekharan, D. P., Coorens, T. H. H., Maughan, E. F., Beal, K. M., Menzies, A. H., Millar, F. R., Anderson, E. L., et al. (2020) · Nature · doi:10.1038/s41586-020-1961-1 · Cited by 545
Self-citationSignatures of copy number alterations in human cancer
Steele, C. D., Abbasi, A., Islam, S. M. A., Bowes, A. L., Khandekar, A., Haase, K., Hames-Fathi, S., Ajayi, D., Verfaillie, A., Dhami, P., et al. (2022) · Nature · doi:10.1038/s41586-022-04738-6 · Cited by 487
Self-citationDrost, J., van Boxtel, R., Blokzijl, F., Mizutani, T., Sasaki, N., Sasselli, V., de Ligt, J., Behjati, S., Grolleman, J. E., van Wezel, T., et al. (2017) · Science · doi:10.1126/science.aao3130 · Cited by 461
Self-citationRodgers, K. M., Udesky, J. O., Rudel, R. A., & Brody, J. G. (2017) · Environmental Research · doi:10.1016/j.envres.2017.08.045 · Cited by 462
“Recent results suggest that some carcinogens, such as ionizing radiation and tobacco smoke, appear to produce a distinctive mutation signature in the tumor that can be discerned with DNA sequencing (Alexandrov et al., 2016; Behjati et al., 2016), and these signatures may be useful for retrospective exposure assessment…”
BackgroundKlempner, S. J., Fabrizio, D. A., Bane, S., Reinhart, M. L., Peoples, T., Ali, S. M., Sokol, E. S., Frampton, G. M., Schrock, A. B., Anhorn, R., et al. (2019) · The Oncologist · doi:10.1634/theoncologist.2019-0244 · Cited by 411
“Exposure to environmental carcinogens, such as cigarette smoke and ultraviolet radiation, has been shown to cause cancers with the highest number of somatic mutations [13, 40, 41].”
BackgroundThe mutational landscape of human somatic and germline cells
Moore, L., Cagan, A., Coorens, T. H. H., Neville, M. D. C., Sanghvi, R., Sanders, M. A., Oliver, T. R. W., Leongamornlert, D., Ellis, P., Noorani, A., et al. (2021) · Nature · doi:10.1038/s41586-021-03822-7 · Cited by 379
Self-citationWhole genome sequencing analysis for cancer genomics and precision medicine
Nakagawa, H., & Fujita, M. (2018) · Cancer Science · doi:10.1111/cas.13505 · Cited by 387
Self-citationImproving radiotherapy in cancer treatment: Promises and challenges
Chen, H. H. W., & Kuo, M. T. (2017) · Oncotarget · doi:10.18632/oncotarget.18409 · Cited by 398
“These observations suggest that exposures to mutagens such as ultraviolet light in melanoma and tobacco smoking [145] in NSCLC may increase mutational loads leading to increased immunogenic neoantigens production.”
BackgroundGenomic characterization of biliary tract cancers identifies driver genes and predisposing mutations
Wardell, C. P., Fujita, M., Yamada, T., Simbolo, M., Fassan, M., Karlić, R., Polak, P. P., Kim, J., Hatanaka, Y., Maejima, K., et al. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.01.009 · Cited by 377
Self-citationUncovering novel mutational signatures by de novo extraction with SigProfilerExtractor
Islam, S. M. A., Díaz‐Gay, M., Wu, Y., Barnes, M. D., Vangara, R., Bergstrom, E. N., He, Y., Vella, M., Wang, J., Teague, J. W., et al. (2022) · Cell Genomics · doi:10.1016/j.xgen.2022.100179 · Cited by 364
Self-citationLeader, A. M., Grout, J. A., Maier, B. B., Nabet, B. Y., Park, M. D., Tabachnikova, A., Chang, C., Walker, L. A., Lansky, A., Bérichel, J. L., et al. (2021) · Cancer Cell · doi:10.1016/j.ccell.2021.10.009 · Cited by 370
Electrochemical biosensors for the detection of lung cancer biomarkers: A review
Khanmohammadi, A., Aghaie, A. B. G., Vahedi, E., Qazvini, A., Ghanei, M., Afkhami, A., Hajian, A., & Bagheri, H. (2019) · Talanta · doi:10.1016/j.talanta.2019.120251 · Cited by 358
Cigarette smoking and telomere length: A systematic review of 84 studies and meta-analysis
Astuti, Y., Wardhana, A. P., Watkins, J. A., & Wulaningsih, W. (2017) · Environmental Research · doi:10.1016/j.envres.2017.06.038 · Cited by 341
“In addition, the special cap structure at the end of telomeric repeats, formed by 3’ G-strand overhang and telomere associated binding proteins, prevent recognition of the linear chromosome ends as DNA double strand break by the DNA repair machinery that may result in chromosome fusions (Griffith et al., 1999; Longhes…”
BackgroundInfluentialSigProfilerMatrixGenerator: a tool for visualizing and exploring patterns of small mutational events
Bergstrom, E. N., Huang, M. N., Mahto, U., Barnes, M. D., Stratton, M. R., Rozen, S., & Alexandrov, L. B. (2019) · BMC Genomics · doi:10.1186/s12864-019-6041-2 · Cited by 305
Self-citationExtensive heterogeneity in somatic mutation and selection in the human bladder
Lawson, A. R. J., Abascal, F., Coorens, T. H. H., Hooks, Y., O’Neill, L., Latimer, C., Raine, K., Sanders, M. A., Warren, A. Y., Mahbubani, K. T. A., et al. (2020) · Science · doi:10.1126/science.aba8347 · Cited by 311
Self-citationThe mutational footprints of cancer therapies
Pich, O., Muiños, F., Lolkema, M. P., Steeghs, N., Gonzalez-Perez, A., & Lopez-Bigas, N. (2019) · Nature Genetics · doi:10.1038/s41588-019-0525-5 · Cited by 309
Inman, G. J., Wang, J., Nagano, A., Alexandrov, L. B., Purdie, K. J., Taylor, R. G., Sherwood, V., Thomson, J., Hogan, S., Spender, L. C., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-06027-1 · Cited by 310
Self-citationUrea Cycle Dysregulation Generates Clinically Relevant Genomic and Biochemical Signatures
Lee, J. S., Adler, L. N., Karathia, H., Carmel, N. N., Rabinovich, S., Auslander, N., Keshet, R., Stettner, N., Silberman, A., Agemy, L., et al. (2018) · Cell · doi:10.1016/j.cell.2018.07.019 · Cited by 304
“Evidently, lung cancer (LUAD, LUSC) samples are notable outliers, probably because they are confounded with a smoking mutational signature (Alexandrov et al., 2016) enriched with transversion mutations.”
Vineis, P., Robinson, O., Chadeau‐Hyam, M., Dehghan, A., Mudway, I., & Dagnino, S. (2020) · Environment International · doi:10.1016/j.envint.2020.105887 · Cited by 324
Self-citationLetouzé, É., Shinde, J., Renault, V., Couchy, G., Blanc, J., Tubacher, E., Bayard, Q., Bacq, D., Meyer, V., Semhoun, J., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01358-x · Cited by 303
Lung cancer in patients who have never smoked — an emerging disease
LoPiccolo, J., Gusev, A., Christiani, D. C., & Janne, P. A. (2024) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-023-00844-0 · Cited by 320
“…demonstrated an increased burden of somatic mutations and several distinct mutational signatures in tumours from patients with a history of tobacco smoking, with total base substitutions nearly fivefold higher in LUADs from such patients compared with LUADs from patients who have never smoked 40 .”
InfluentialSholl, L. M., Hirsch, F. R., Hwang, D. M., Botling, J., López‐Ríos, F., Bubendorf, L., Mino-Kenudson, M. A., Roden, A. C., Beasley, M. B., Borczuk, A., et al. (2020) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2020.05.019 · Cited by 286
Smokeless tobacco and cigarette smoking: chemical mechanisms and cancer prevention
Hecht, S. S., & Hatsukami, D. K. (2022) · Nature reviews. Cancer · doi:10.1038/s41568-021-00423-4 · Cited by 300
Identification of cancer driver genes based on nucleotide context
Dietlein, F., Weghorn, D., Taylor-Weiner, A. N., Richters, A., Reardon, B. M., Liu, D., Lander, E. S., Allen, E. M. V., & Sunyaev, S. R. (2020) · Nature Genetics · doi:10.1038/s41588-019-0572-y · Cited by 251
Lin, D., Wang, M., & Koeffler, H. P. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.06.066 · Cited by 249
Riess, J. W., Gandara, D. R., Frampton, G. M., Madison, R., Peled, N., Bufill, J. A., Dy, G. K., Ou, S.-H. I., Stephens, P. J., McPherson, J. D., et al. (2018) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2018.06.019 · Cited by 240
“Median age, y (range) 65 (6-99) 65 (25-95) 63 (14-90) 0.”
Human papillomavirus and the landscape of secondary genetic alterations in oral cancersPreprint
Gillison, M. L., Akagi, K., Xiao, W., Jiang, B., Pickard, R. K. L., Li, J., Swanson, B. J., Agrawal, A. D., Zucker, M., Stache-Crain, B., et al. (2018) · Genome Research · doi:10.1101/gr.241141.118 · Cited by 241
“…16, with a predominance of T>C substitutions occurring in a 5′-ATN-3′ sequence context, was significantly greater in HPV-negative than HPV-positive cancers, whether measured by mean fraction (14.2% vs. 1.8%, P=5.05× 10−7) or number (1457 vs. 106, P=1.96×10−6) of variants (Alexandrov et al. 2016).”
BackgroundInfluentialA Decade of GWAS Results in Lung Cancer
Bossé, Y., & Amos, C. I. (2017) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-16-0794 · Cited by 237
“A wellorchestrated community effort thus seems necessary (79).”
BackgroundEnter the Matrix: Factorization Uncovers Knowledge from Omics
Stein-O’Brien, G., Arora, R., Culhane, A. C., Favorov, A. V., Garmire, L. X., Greene, C. S., Goff, L. A., Li, Y., Ngom, A., Ochs, M. F., et al. (2018) · Trends in Genetics · doi:10.1016/j.tig.2018.07.003 · Cited by 228
“For example, MF has also been applied to define mutational signatures in cancer [13,14], allele combinations in phenotypes [15], transcript regulation of genes [16], and distributions of transcript lengths [17], as well as to discriminate peptides in mass spectrometry proteomics [18].”
MethodMutational signatures are jointly shaped by DNA damage and repair
Volkova, N. V., Meier, B., González‐Huici, V., Bertolini, S., González, S., Vöhringer, H. S., Abascal, F., Martincorena, I., Campbell, P. J., Gartner, A., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15912-7 · Cited by 227
Self-citationWang, G.-Z., Zhang, L., Zhao, X.-C., Gao, S.-H., Qu, L.-W., Yu, H., Fang, W.-F., Zhou, Y.-C., Liang, F., Zhang, C., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-08887-7 · Cited by 213
Clustered Mutation Signatures Reveal that Error-Prone DNA Repair Targets Mutations to Active Genes
Supek, F., & Lehner, B. (2017) · Cell · doi:10.1016/j.cell.2017.07.003 · Cited by 192
“Of the previously determined general (non-clustered) signatures, two are known to be associated to tobacco smoking, signature 4 and signature 5 (henceforth, S4 and S5) (Alexandrov et al., 2016).”
Context-Specific Determinants of the Immunosuppressive Tumor Microenvironment in Pancreatic Cancer
Falcomatà, C., Bärthel, S., Schneider, G., Rad, R., Schmidt‐Supprian, M., & Saur, D. (2023) · Cancer Discovery · doi:10.1158/2159-8290.cd-22-0876 · Cited by 224
“Smoke not only increases the mutational load of the tumors (134, 135) but also contributes to immunosuppression in a context-dependent manner in different cancer types, including PDAC (136, 137).”
BackgroundRodrigues, D. N., Rescigno, P., Liu, D., Yuan, W., Carreira, S., Lambros, M. B. K., Seed, G., Mateo, J., Riisnaes, R., Mullane, S. A., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci121924 · Cited by 209
“org Beyond mutations in canonical MMR genes, we hypothesized that signatures of mutational processes in individual tumors would shed light on DNA repair deficiencies (10, 16, 17) that may associate with distinct immunologic subtypes.”
BackgroundCausal Inference in Cancer Epidemiology: What Is the Role of Mendelian Randomization?
Yarmolinsky, J., Wade, K. H., Richmond, R. C., Langdon, R., Bull, C. J., Tilling, K. M., Relton, C. L., Lewis, S. J., Smith, G. D., & Martin, R. M. (2018) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-17-1177 · Cited by 189
“MR for identifying causality of mutational signatures Large-scale analysis of the genomes of thousands of patients with cancer has helped to reveal somatic "mutational signatures" (distinctive somatic mutational patterns left by unique carcinogenic agents) involved in the development of their tumors (158, 159).”
BackgroundTumour predisposition and cancer syndromes as models to study gene–environment interactions
Carbone, M., Arron, S. T., Beutler, B., Bononi, A., Cavenee, W. K., Cleaver, J. E., Croce, C. M., D’Andrea, A. D., Foulkes, W. D., Gaudino, G., et al. (2020) · Nature reviews. Cancer · doi:10.1038/s41568-020-0265-y · Cited by 198
Moody, S., Senkin, S., Islam, S. M. A., Wang, J., Nasrollahzadeh, D., Penha, R. C. C., Fitzgerald, S. F., Bergstrom, E. N., Atkins, J., He, Y., et al. (2021) · Nature Genetics · doi:10.1038/s41588-021-00928-6 · Cited by 192
Self-citationJha, P. (2020) · eLife · doi:10.7554/elife.49979 · Cited by 201
“…review of the somatic mutations and DNA methylation in cancers of types for which tobacco smoking confers an elevated risk, found that smoking caused multiple mutations, most notably the misreplication of DNA by tobacco carcinogens, or indirect activation of DNA editing (Alexandrov et al., 2016).”
BackgroundMolecular events in neuroendocrine prostate cancer development
Wang, Y., Wang, Y., Ci, X., Choi, S. Y. C., Crea, F., Lin, D., & Wang, Y. Z. (2021) · Nature Reviews Urology · doi:10.1038/s41585-021-00490-0 · Cited by 195
Limitations in predicting the space radiation health risk for exploration astronauts
Chancellor, J. C., Blue, R. S., Cengel, K. A., Auñón-Chancellor, S. M., Rubins, K. H., Katzgraber, H. G., & Kennedy, A. R. (2018) · npj Microgravity · doi:10.1038/s41526-018-0043-2 · Cited by 183
Tobacco Smoking-Associated Alterations in the Immune Microenvironment of Squamous Cell Carcinomas
Desrichard, A., Kuo, F., Chowell, D., Lee, K.-W., Riaz, N., Wong, R. J., Chan, T. A.-T., & Morris, L. G. T. (2018) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djy060 · Cited by 178
“mutational processes occurring over intervening years (1).”
BackgroundMethodSyngeneic animal models of tobacco-associated oral cancer reveal the activity of in situ anti-CTLA-4
Wang, Z., Wu, V. H., Allevato, M. M., Gilardi, M., He, Y., Callejas‐Valera, J. L., Vitale-Cross, L. A., Martı́n, D., Amornphimoltham, P., Mcdermott, J., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-13471-0 · Cited by 177
Self-citationLimitations in predicting the space radiation health risk for exploration astronauts
Chancellor, J. C., Blue, R. S., Cengel, K. A., Auñón-Chancellor, S. M., Rubins, K., Katzgraber, H. G., & Kennedy, A. R. (2018) · Civil War Book Review · Cited by 174
Lung Adenocarcinoma Tumor Origin: A Guide for Personalized Medicine
Seguin, L., Durandy, M., & Féral, C. C. (2022) · Cancers · doi:10.3390/cancers14071759 · Cited by 188
“Tobacco smoke contains many toxic, carcinogenic and mutagenic chemicals that exert their genotoxic effect by causing double-stranded DNA breaks and the generation of reactive oxygen species (ROS), causing mutation in vital genes [9,57].”
BackgroundSimpson, K., Stoney, R., Frese, K. K., Simms, N., Rowe, W., Pearce, S. P., Humphrey, S., Booth, L., Morgan, D., Dynowski, M., et al. (2020) · Nature Cancer · doi:10.1038/s43018-020-0046-2 · Cited by 176
Local Determinants of the Mutational Landscape of the Human Genome
González-Pérez, A., Sabarinathan, R., & López-Bigas, N. (2019) · Cell · doi:10.1016/j.cell.2019.02.051 · Cited by 172
The mutational signature profile of known and suspected human carcinogens in mice
Riva, L., Pandiri, A. R., Li, Y. R., Droop, A., Hewinson, J., Quail, M. A., Iyer, V., Shepherd, R., Herbert, R. A., Campbell, P. J., et al. (2020) · Nature Genetics · doi:10.1038/s41588-020-0692-4 · Cited by 169
Self-citationA practical guide for mutational signature analysis in hematological malignancies
Maura, F., Degasperi, A., Nadeu, F., Leongamornlert, D., Davies, H., Moore, L., Royo, R., Ziccheddu, B., Puente, X. S., Avet-Loiseau, H., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11037-8 · Cited by 184
Self-citationAssociation between Smoking History and Tumor Mutation Burden in Advanced Non–Small Cell Lung Cancer
Wang, X., Ricciuti, B., Nguyen, T. T., Li, X., Rabin, M. S., Awad, M. M., Lin, X., Johnson, B. E., & Christiani, D. C. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-3991 · Cited by 163
The Underlying Tumor Genomics of Predominant Histologic Subtypes in Lung Adenocarcinoma
Caso, R., Sánchez-Vega, F., Tan, K. S., Mastrogiacomo, B., Zhou, J. H., Jones, G. D., Nguyen, B., Schultz, N. D., Connolly, J. G., Brandt, W. S., et al. (2020) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2020.08.005 · Cited by 158
Park, J. S., Lee, J., Jung, E. S., Kim, M.-H., Kim, I. B., Son, H., Kim, S., Kim, S., Park, Y. M., Mook-Jung, I., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11000-7 · Cited by 155
PD-L1 expression testing in non-small cell lung cancer
Teixidó, C., Vilariño, N., Reyes, R., & Reguart, N. (2018) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758835918763493 · Cited by 159
Epidemiology and Molecular Biology of Head and Neck Cancer
Jou, A., & Heß, J. (2017) · Oncology Research and Treatment · doi:10.1159/000477127 · Cited by 154
Molecular mechanisms of the preventable causes of cancer in the United StatesPreprint
Golemis, E. A., Scheet, P. A., Beck, T. N., Scolnick, E. M., Hunter, D. J., Hawk, E. T., & Hopkins, N. H. (2018) · Genes & Development · doi:10.1101/gad.314849.118 · Cited by 164
“…was absent; instead, these cancers were characterized by signatures associated with the APOBEC (apolipoprotein B mRNA-editing catalytic polypeptide) deamination machinery and a “clock-like” signature known to occur over time in many tissues as a correlate of aging (Alexandrov et al. 2016).”
BackgroundInfluentialValidating the concept of mutational signatures with isogenic cell models
Zou, X., Owusu, M., Harris, R., Jackson, S. P., Loizou, J. I., & Nik‐Zainal, S. (2018) · Nature Communications · doi:10.1038/s41467-018-04052-8 · Cited by 144
Self-citationComprehensive Genomic Profiling of Neuroendocrine Carcinomas of the Gastrointestinal System
Yachida, S., Totoki, Y., Noë, M., Nakatani, Y., Horie, M., Kawasaki, K., Nakamura, H., Saito-Adachi, M., Suzuki, M., Takai, E., et al. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-21-0669 · Cited by 161
Self-citationGenomic characterization of malignant progression in neoplastic pancreatic cysts
Noë, M., Niknafs, N., Fischer, C. G., Hackeng, W. M., Guthrie, V. B., Hosoda, W., Debeljak, M., Papp, E., Adleff, V., White, J. R., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17917-8 · Cited by 150
Clonal dynamics in early human embryogenesis inferred from somatic mutation
Park, S., Mali, N. M., Kim, R., Choi, J., Lee, J., Lim, J., Park, J. M., Park, J. W., Kim, D., Kim, T., et al. (2021) · Nature · doi:10.1038/s41586-021-03786-8 · Cited by 146
Self-citationImpact of risk factors on early cancer evolution
Weeden, C. E., Hill, W., Lim, E. L., Gronroos, E. C., & Swanton, C. (2023) · Cell · doi:10.1016/j.cell.2023.03.013 · Cited by 147
Molecular profiles of small cell lung cancer subtypes: Therapeutic implications
Solta, A., Megyesfalvi, Z., Bárány, N., Valkó, Z., Bugyik, E., Lang, C., Ferencz, B., Paku, S., Lantos, A., Fillinger, J., et al. (2021) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2021.02.004 · Cited by 143
“Most SCLC patients are current or former heavy smokers resulting in a high tumor mutational burden (TMB) (with C:G>A:T transversions being the most common type of base substitutions).(9,10) Early detection strategies are mostly ineffective for SCLC even among high-risk populations, and there have been no significant i…”
Dancing with the DNA damage response: next-generation anti-cancer therapeutic strategies
Minchom, A. R., Aversa, C., & Lopez, J. S. (2018) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758835918786658 · Cited by 138
Precision oncology in the age of integrative genomics
Kumar‐Sinha, C., & Chinnaiyan, A. M. (2018) · Nature Biotechnology · doi:10.1038/nbt.4017 · Cited by 138
Lyu, H., Li, M., Jiang, Z., Liu, Z., & Wang, X. (2019) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2019.07.009 · Cited by 137
“HPV and smoking are important factors in the rise of non-smoker HNSCCs and smoker HNSCCs, respectively [13,41].”
BackgroundWidman, A. J., Shah, M. J., Frydendahl, A., Halmos, D., Khamnei, C. C., Øgaard, N., Rajagopalan, S., Arora, A., Deshpande, A. S., Hooper, W. F., et al. (2024) · Nature Medicine · doi:10.1038/s41591-024-03040-4 · Cited by 148
“We evaluated features such as single-base substitution (SBS) sequence patterns 18,19 , cfDNA fragment size 20–22 and regional predilection for somatic mutagenesis 23–28 across cancer types (Fig.”
Stress, epigenetics, and aging: Unraveling the intricate crosstalk
Wu, Z., Qu, J. T., Zhang, W., & Liu, G. (2023) · Molecular Cell · doi:10.1016/j.molcel.2023.10.006 · Cited by 145
Evolutionary trajectories of small cell lung cancer under therapy
George, J., Maas, L., Abedpour, N., Cartolano, M., Kaiser, L., Fischer, R. N., Scheel, A. H., Weber, J.-P., Hellmich, M., Bosco, G., et al. (2024) · Nature · doi:10.1038/s41586-024-07177-7 · Cited by 145
“Confirming previous studies in lung cancer 18–21 , age-like and tobacco-associated processes dominated within the mutations of the common ancestor, which correlated with the level of smoking in these patients (Spearman correlation = 0.39, ** P < 0.01; Fig.”
InfluentialVenkatesan, S., Angelova, M., Puttick, C., Zhai, H.-R., Caswell, D. R., Lu, W.-T., Dietzen, M., Galanos, P., Evangelou, K., Bellelli, R., et al. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-0725 · Cited by 130
“The initiating factor for this feed forward loop might be caused by endogenous factors, such as oncogene-induced replication stress (60) or exogenous factors such as tobacco smoking (61).”
BackgroundHuang, Z., Sun, S., Lee, M., Maslov, A. Y., Shi, M., Waldman, S., Marsh, A., Siddiqui, T., Dong, X., Peter, Y., et al. (2022) · Nature Genetics · doi:10.1038/s41588-022-01035-w · Cited by 125
Aier, I., Semwal, R., Sharma, A., & Varadwaj, P. K. (2018) · Cancer Epidemiology · doi:10.1016/j.canep.2018.12.001 · Cited by 139
Su, S., Lin, C., Liu, Y., Fan, W., Chen, M., Yu, C.-P., Yang, W., Su, C., Chuang, C., Li, W., et al. (2017) · Theranostics · doi:10.7150/thno.18551 · Cited by 136
“The collective somatic mutations within a cancer genome were elucidated to be the readout of certain oncogenic patterns that are associated with mutagenic exposures or defects in DNA maintenance [13-15].”
BackgroundHeated Tobacco Products: A Review of Current Knowledge and Initial Assessments
Mallock, N., Pieper, E., Hutzler, C., Henkler, F., & Luch, A. (2019) · Frontiers in Public Health · doi:10.3389/fpubh.2019.00287 · Cited by 140
“A recent study has shown that tobacco smoking increases not only the risk for lung cancer, but also for at least 17 different malignant diseases in humans (5); therefore, successful tobacco control can save millions of lives.”
BackgroundPrecancer Atlas to Drive Precision Prevention Trials
Spira, A. E., Yurgelun, M. B. B., Alexandrov, L. B., Rao, A., Bejar, R., Polyák, K., Giannakis, M., Shilatifard, A., Finn, O. J., Dhodapkar, M., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-2346 · Cited by 134
“Interestingly, a recent study demonstrated the increased rate of one mutational clock to be mechanistically linked to tobacco smoking (144).”
BackgroundSelf-citationWeng, M.-W., Lee, H., Park, S., Hu, Y., Wang, H.-T., Chen, L., Rom, W. N., Huang, W. C. W., Lepor, H., Wu, X., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1804869115 · Cited by 128
“It induces G-to-T transversion mutations similar to TS-induced mutations in the p53 gene (6, 54).”
BackgroundCho, R. J., Alexandrov, L. B., den Breems, N. Y., Atanasova, V. S., Farshchian, M., Purdom, E. A., Nguyen, T., Coarfa, C., Rajapakshe, K., di Prisco, M., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aas9668 · Cited by 130
“Instead, APOBEC mutation has been associated with DNA replication stress (35), and particulate matter in tobacco smoke has been hypothesized to induce inflammation and APOBEC activity (10).”
BackgroundSelf-citationSharma, A., Merritt, E., Hu, X., Cruz, A., Jiang, C., Sarkodie, H., Zhou, Z. M., Malhotra, J. D., Riedlinger, G., & De, S. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.10.045 · Cited by 124
“Also, analysis was done both using all 30 signatures as well as selected signatures relevant to lung cancer biology (Alexandrov et al., 2016).”
MethodSpecific Gut Microbiome and Serum Metabolome Changes in Lung Cancer Patients
Zhao, F., An, R., Wang, L., Shan, J., & Wang, X. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.725284 · Cited by 129
An integrative analysis of the age-associated multi-omic landscape across cancers
Chatsirisupachai, K., Lesluyes, T., Paraoan, L., Loo, P. V., & de Magalhães, J. P. (2021) · Nature Communications · doi:10.1038/s41467-021-22560-y · Cited by 128
Lin, D., Dinh, H. Q., Xie, J., Mayakonda, A., Silva, T. C., Jiang, Y., Ding, L., He, J., Xu, X., Hao, J., et al. (2017) · Gut · doi:10.1136/gutjnl-2017-314607 · Cited by 119
Pich, O., Muiños, F., Sabarinathan, R., Reyes-Salazar, I., Gonzalez-Perez, A., & Lopez-Bigas, N. (2018) · Cell · doi:10.1016/j.cell.2018.10.004 · Cited by 123
“The periodicity of mutations contributed by signatures 4 –associated to DNA adducts generated by tobacco carcinogens (Alexandrov et al., 2016)– follows the same orientation as signature 7 (phase=-1; SNR=78.”
The clinical utility of tumor mutational burden in non-small cell lung cancer
Greillier, L., Tomasini, P., & Barlési, F. (2018) · Translational Lung Cancer Research · doi:10.21037/tlcr.2018.10.08 · Cited by 123
Somatic mutation distributions in cancer genomes vary with three-dimensional chromatin structure
Akdemir, K. C., Le, V. T., Kim, J. M., Killcoyne, S., King, D. A., Lin, Y., Tian, Y., Inoue, A., Amin, S. B., Robinson, F. S., et al. (2020) · Nature Genetics · doi:10.1038/s41588-020-0708-0 · Cited by 116
Self-citationAlterations of fecal bacterial communities in patients with lung cancer.
Zhang, W., Zhao, S., Luo, J., Dong, X., Hao, Y., Li, H., Shan, L., Zhou, Y., Shi, H., Zhang, Z.-Y., et al. (2018) · Europe PMC (PubMed Central) · Cited by 128
Piberger, A. L., Bowry, A., Kelly, R. D., Walker, A. K., González‐Acosta, D., Bailey, L. J., Doherty, A. J., Méndez, J., Morris, J. R., Bryant, H. E., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19570-7 · Cited by 119
Tumor mutational burden as a predictor of immunotherapy response in breast cancer
O’Meara, T. A., & Tolaney, S. M. (2021) · Oncotarget · doi:10.18632/oncotarget.27877 · Cited by 122
“For example, carcinogen-related DNA damage, dominated by C>A transversions, is thought to be most predictive of ICB response [22] in melanoma and lung cancer.”
BackgroundPortrait of a cancer: mutational signature analyses for cancer diagnostics
Van Hoeck, A., Tjoonk, N. H., van Boxtel, R., & Cuppen, E. (2019) · BMC Cancer · doi:10.1186/s12885-019-5677-2 · Cited by 107
de la Iglesia, J. V., Slebos, R. J. C., Martin‐Gomez, L., Wang, X., Teer, J. K., Tan, A. C., Gerke, T. A., Aden-Buie, G., van Veen, T., Masannat, J., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-1769 · Cited by 120
“However, in this cohort, we did not find evidence for an association between smoking status and TMB (Supplementary Fig.”
BackgroundInfluentialRicciuti, B., Alessi, J. V., Elkrief, A., Wang, X., Cortellini, A., Li, Y. Y., Vaz, V. R., Gupta, H., Pecci, F., Barrichello, A., et al. (2022) · Annals of Oncology · doi:10.1016/j.annonc.2022.07.005 · Cited by 112
Metadata
- Authors
- Alexandrov, L. B., Ju, Y. S., Haase, K., Van Loo, P., Martincorena, I., Nik-Zainal, S., Totoki, Y., Fujimoto, A., Nakagawa, H., Shibata, T., Campbell, P. J., Vineis, P., Phillips, D. H., & Stratton, M. R.
- Affiliations
- Los Alamos National Laboratory (US)
- Korea Advanced Institute of Science and Technology (KR)
- The Francis Crick Institute (GB)
- The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK.
- Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton CB10 1SA, Cambridgeshire, UK.
- National Cancer Center Research Institute (JP)
- Kyoto University (JP)
- RIKEN Center for Integrative Medical Sciences (JP)
- Institute of Medical Science, The University of Tokyo (JP)
- University of Cambridge (GB)
- Public Health England (GB)
- King's College London (GB)
- Wellcome Sanger Institute (GB)
- Corresponding author
- Alexandrov, Ludmil B.
- Stratton, Michael R.
- ORCID
- Venue
- Science
- Published
- 2016-11-04
- Volume
- 354
- Issue
- 6312
- Pages
- 618-622
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC6141049
- OpenAlex
- W2547187744
- Cited by
- 1,100
- References
- 54
- Citations by year
- 2026: 70 · 2025: 89 · 2024: 103 · 2023: 121 · 2022: 115 · 2021: 148 · 2020: 149 · 2019: 117 · 2018: 95 · 2017: 90 · 2016: 3
- FWCI
- 42.36
- Type
- journal article
- Language
- en
- Open access
- green
- doi.org
- Locations
- Science (publishedVersion)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Figshare (submittedVersion, cc-by)
- Research Portal (King's College London) (submittedVersion, other-oa)
- Lirias (submittedVersion)
- OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information) (submittedVersion)
- Spiral (Imperial College London) (submittedVersion)
- Funders
- Wellcome Trust Intermediate Fellowship (WT100183MA)
- Wellcome Trust Senior Clinical Research Fellowship (WT088340MA)
- U.S. Department of Energy (DOE) National Nuclear Security Administration (DE-AC52-06NA25396)
- Francis Crick Institute
- UK MRC (FC001202)
- Cancer Research UK (FC001202, C313/A14329)
- Wellcome Trust (98051, FC001202, 101126/Z/13/Z, 101126/B/13/Z)
- National Institute for Health Research (NIHR)
- EXPOSOMICS (308610-FP7)
- Japan Agency for Medical Research and Development (15ck0106094h0002)
- National Cancer Center Research and Development Funds (26-A-5)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Carcinogens and Genotoxicity Assessment
- Keywords
- smoking, mutational signatures, somatic mutations, DNA methylation, tobacco-related cancer, APOBEC cytidine deaminases, tobacco carcinogens, mutational burden, cancer risk
- MeSH terms
- APOBEC Deaminases, Carcinogens, DNA Damage, Humans, Mutation, Neoplasms, Risk, Smoking, Tobacco Products, Nicotiana, CpG Islands, DNA Methylation, Exome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
